Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Breast cancer molecular phenotype and the use of HER2-targeted agents influence the accuracy of breast MRI after neoadjuvant chemotherapy.

Annals of surgery - 1 Jan 2013

Moon Hyeong-Gon, Han Wonshik, Ahn Soo Kyung, Cho Nariya, Moon Woo Kyung, Im Seock-Ah, Park In Ae, Noh Dong-Young

Abstract excerpt

OBJECTIVE: To investigate whether the accuracy of magnetic resonance imaging (MRI) after neoadjuvant systemic therapy (NST) is affected by molecular features of primary breast cancer and the use of human epidermal growth factor receptor 2 (HER2)-targeted agents. BACKGROUND: Improved understanding of factors affecting the accuracy of breast MRI after NST can lead to more tailored use of MRI in deciding surgical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to Mastectomy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Neoadjuvant Therapy

Share to Preoperative Care

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Share to Trastuzumab

Source

Identifiers

PMID: 22968080
DOI: 10.1097/SLA.0b013e3182686bd9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Breast cancer molecular phenotype and the use of HER2-targeted agents influence the accuracy of breast MRI after neoadjuvant chemotherapy.PMID 22968080Read ↗

Early Identification of Breast Cancer Patients Achieving Radiological Complete Response to NAC: A Clinicopathological and MRI-Based ApproachSemantic proximity Read ↗

Magnetic Resonance Imaging Phenotypes of Breast Cancer Molecular Subtypes: A Systematic Review.Semantic proximity Read ↗

Bridging MRI and Oncotype DX: Multimodal Keys to Breast Cancer PrognosisSemantic proximity Read ↗

Mid-treatment radiologic response as an early predictor of pathologic response in TNBC in the era of pembrolizumabSemantic proximity Read ↗

Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment.Semantic proximity Read ↗

Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.Semantic proximity Read ↗

Breast conservation following neoadjuvant therapy for breast cancer in the modern era: Are we losing the opportunity?Semantic proximity Read ↗

Imaging features of HER2 overexpression in breast cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

Diffusion-weighted MRI characteristics associated with prognostic pathological factors and recurrence risk in invasive ER+/HER2- breast cancers.Semantic proximity Read ↗

Radiomics MRI for lymph node status prediction in breast cancer patients: the state of art.Semantic proximity Read ↗

[Immunohistochemical phenotype of breast carcinomas predicts the effectiveness of primary systemic therapy].Semantic proximity Read ↗

DCE-MRI Based Machine Learning Predictor for HER2-Positive Breast Cancer: A Feasibility and Validation Multicenter StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.